Based on the promoter methylation in bladder cancer cell lines, the ST6GAL1 promoter methylation in primary human bladder cancer samples including CIS (n = 82) was analyzed using MSP technology. This evidence concerns the gene ST6GAL1 and in situ carcinoma.